Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Bioabsorbable Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global bioabsorbable stents market size reached US$ 379.1 Million in 2022. Looking forward, the publisher expects the market to reach US$ 620.2 Million by 2028, exhibiting a CAGR of 8.55% during 2022-2028.
Bioabsorbable stents (BRS) are coated with an antiproliferative drug or gene that dissolves over time to restore vessel patency and permit remodeling while retaining recoil. It helps in regulating blood flow at branch points and limiting the amount of blood to areas of the vascular network while maintaining the flow at low perfusion.
It also improves lesion imaging with cardiac computed tomography (CT) and magnetic resonance imaging (MRI). In addition, it leaves no residual scaffold, reduces vessel irritation and inflammation, and facilitates repeat treatments to the same site. As a result, BRS finds extensive applications in hospitals and cardiac centers across the globe.
Bioabsorbable Stents Market Trends:
The growing prevalence of cardiovascular diseases due to an unhealthy diet, physical inactivity, and excessive consumption of tobacco and alcohol represents one of the factors driving the market. Moreover, there is a rise in the utilization of percutaneous coronary intervention (PCI) procedures to open a blocked artery for carrying oxygen-rich blood through the body. This, along with the expanding healthcare industry, is contributing to the growth of the market.
Besides this, the increasing awareness among the masses about the benefits of bioabsorbable stents is offering lucrative growth opportunities to industry investors.
In addition, the growing demand for minimally invasive procedures due to less postoperative pain, fewer operative and postoperative complications, shortened hospital stay, and faster recovery times is positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce SLENDER integrated delivery system (IDS) fixed-wire and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems to treat coronary artery disease. They are also focusing on developing polymer-based stents, which is expected to bolster the growth of the market.
Key Market Segmentation:
Breakup by Biomaterial:
- Polymer-based Bioabsorbable Stents
- Metal-based Bioabsorbable Stents
Breakup by Absorption Rate:
- Slow-Absorption Stents
- Fast-Absorption Stents
Breakup by Application:
- Coronary Artery Disease
- Peripheral Artery Disease
Breakup by End User:
- Hospitals
- Cardiac Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key Questions Answered in This Report
1. What was the size of the global bioabsorbable stents market in 2022?
2. What is the expected growth rate of the global bioabsorbable stents market during 2023-2028?
3. What are the key factors driving the global bioabsorbable stents market?
4. What has been the impact of COVID-19 on the global bioabsorbable stents market?
5. What is the breakup of the global bioabsorbable stents market based on the biomaterial?
6. What is the breakup of the global bioabsorbable stents market based on the absorption rate?
7. What is the breakup of the global bioabsorbable stents market based on the application?
8. What is the breakup of the global bioabsorbable stents market based on the end user?
9. What are the key regions in the global bioabsorbable stents market?
10. Who are the key players/companies in the global bioabsorbable stents market?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
5 Global Bioabsorbable Stents Market
6 Market Breakup by Biomaterial
7 Market Breakup by Absorption Rate
8 Market Breakup by Application
9 Market Breakup by End User
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
Companies Mentioned
- Abbott Laboratories
- Arterius Limited
- B. Braun SE
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Elixir Medical Corporation
- Kyoto Medical Planning Co. Ltd.
- Lepu Medical Technology (Beijing) Co. Ltd.
- Meril Life Sciences Pvt. Ltd.
- Reva Medical LLC
- Terumo Corporation.
For more information about this report visit https://www.researchandmarkets.com/r/uw7p08
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
